Inspire Medical Systems, Inc. (INSP) vs UroGen Pharma Ltd. (URGN)

A side-by-side comparison of Inspire Medical Systems, Inc. and UroGen Pharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INSP vs URGN

growth of $100 · dividends reinvested · last 8y
INSP +183.2% (+13.9%/yr)URGN -25.3% (-3.6%/yr)INSP compounded faster over this window
05001kStart $1002020202220242026$283$75
INSP URGN

INSP vs URGN: by the numbers

  • •URGN is the larger company ($2.02B vs $1.97B market cap).
  • •INSP is profitable (15.03% net margin) while URGN runs a net loss (-51.73%).
  • •URGN grew revenue faster over the past five years (42.66% vs 38.69% CAGR).

Metrics side by side

Valuation

MetricINSPURGN
P/E ratio14.76N/A
Forward P/E57.10N/A
P/S ratio2.1910.70
P/B ratio2.39N/A
EV / EBITDA26.26N/A
FCF yield5.94%N/A

Profitability

MetricINSPURGN
Gross margin86.13%90.85%
Operating margin6.02%-113.73%
Net margin15.03%-51.73%
ROE16.36%N/A
ROIC6.33%-34.96%

Growth (annualized)

MetricINSPURGN
Revenue CAGR (5Y)38.69%42.66%
Total return CAGR (5Y)-21.38%20.32%

Frequently asked

Which has grown faster, INSP or URGN?
Over the past five years, URGN grew revenue faster — INSP at a 38.69% CAGR versus URGN at 42.66%.
Is INSP or URGN more profitable?
INSP runs the higher net margin — INSP at 15.03% versus URGN at -51.73%.
How have INSP and URGN total returns compared?
Over the past 5 years, INSP delivered -21.38% and URGN delivered 20.32% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.